Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Med Virol ; 96(6): e29725, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38828936

RESUMEN

Data on post-coronavirus disease (COVID) in healthcare workers (HCWs) are scarce. We aimed to assess prevalence, determinants, and consequences of post-COVID in HCWs. In fall 2022, we performed a cross-sectional survey in a tertiary care hospital with a web-based questionnaire sent to HCWs. Post-COVID was defined as persistent/new symptoms 3 months after acute COVID. Propensity score weighting was performed to assess the impact of post-COVID on return-to-work. 1062 HCWs completed the questionnaire, 713 (68%) reported at least one COVID, and 109 (10%) met the definition for post-COVID, with workplace contamination reported in 51 (47%). On multivariable analysis, risk factors for post-COVID were female gender (p = 0.047), ≥50 years (p = 0.007), immunosuppression (p = 0.004), ≥2 COVID episodes (p = 0.003), and ≥5 symptoms during acute COVID (p = 0.005). Initial sick leave was prescribed for 94 HCWs (86% post-COVID), for a median duration of 7 [7-9] days, and extended for 23. On return-to-work, 91 (84%) had residual symptoms, primarily asthenia/fatigue (72%) and cognitive impairment (25%). Cognitive impairment at return-to-work was associated with post-COVID. Ten HCWs (9%) received a medical diagnosis of post-COVID, 8 consulted the occupational physician, and four required work adaptation. Post-COVID affected 10% of HCWs. Long-term consequences included repeated sick leaves and residual symptoms on return-to-work.


Asunto(s)
COVID-19 , Personal de Salud , Humanos , COVID-19/epidemiología , Masculino , Estudios Transversales , Femenino , Personal de Salud/estadística & datos numéricos , Persona de Mediana Edad , Prevalencia , Adulto , Encuestas y Cuestionarios , Factores de Riesgo , Reinserción al Trabajo/estadística & datos numéricos , SARS-CoV-2 , Ausencia por Enfermedad/estadística & datos numéricos , Síndrome Post Agudo de COVID-19
2.
Medicine (Baltimore) ; 100(20): e25659, 2021 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-34011027

RESUMEN

ABSTRACT: Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI.All patients with UEDI with or without cutaneous necrosis in a university hospital setting between January 2000 to December 2016 were included. Aetiologies, recurrence of UEDI, digital amputation and survival were analyzed retrospectively.Three hundred twenty three patients were included. UEDI due to cardio-embolic disease (DICE) was the highest occurring aetiology with 59 patients (18.3%), followed by DI due to Systemic Sclerosis (SSc) (16.1%), idiopathic causes (11.7%), Thromboangiitis obliterans (TAO) (9.3%), iatrogenic causes (9.3%), and cancer (6.2%). DICE patients tended to be older and featured more cases with arterial hypertension whereas TAO patients smoked more tobacco and cannabis. During follow-up, recurrences were significantly more frequent in SSc than in all other tested groups (P < .0001 vs idiopathic and DICE, P = .003 vs TAO) and among TAO patients when compared to DICE patients (P = .005). The cumulated rate of digital amputation was higher in the SSc group (n = 18) (P = .02) and the TAO group (n = 7) (P = .03) than in DICE (n = 2).This retrospective study suggests that main aetiologies of UEDI are DICE, SSc and idiopathic. This study highlights higher frequency of iatrogenic UEDI than previous studies. UEDI associated with SSc has a poor local prognosis (amputations and recurrences) and DICE a poor survival. UEDI with SSc and TAO are frequently recurrent.


Asunto(s)
Amputación Quirúrgica/estadística & datos numéricos , Dedos/irrigación sanguínea , Isquemia/etiología , Adulto , Anciano , Anciano de 80 o más Años , Embolia/complicaciones , Embolia/epidemiología , Femenino , Dedos/patología , Dedos/cirugía , Estudios de Seguimiento , Humanos , Enfermedad Iatrogénica/epidemiología , Isquemia/epidemiología , Isquemia/cirugía , Estimación de Kaplan-Meier , Masculino , Fumar Marihuana/efectos adversos , Fumar Marihuana/epidemiología , Persona de Mediana Edad , Necrosis/epidemiología , Necrosis/etiología , Necrosis/cirugía , Neoplasias/complicaciones , Neoplasias/epidemiología , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Esclerodermia Sistémica/complicaciones , Esclerodermia Sistémica/epidemiología , Tasa de Supervivencia , Tromboangitis Obliterante/complicaciones , Tromboangitis Obliterante/epidemiología , Trombosis/complicaciones , Trombosis/epidemiología , Fumar Tabaco/efectos adversos , Fumar Tabaco/epidemiología
3.
Autoimmun Rev ; 18(5): 476-483, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30844551

RESUMEN

INTRODUCTION: Juvenile temporal arteritis (JTA) is a recently-described and little-known inflammatory disease and its etiology is undetermined. Less than forty cases have been published. This paper is aimed at reporting the largest JTA series and to compare it to literature data to better evaluate its characteristics at diagnosis, its evolution and treatment options. MATERIAL AND METHODS: We conducted a retrospective and descriptive multicentric study in France by identifying adult patients under the age of 50 which had a pathological temporal artery biopsy owing to the presence of a temporal arteritis. Patients with temporal arteritis as a manifestation of systemic vasculitis were excluded. RESULTS: We included 12 patients and the literature review identified 32 cases described in 27 articles, thus a total of 44 patients - 34 men and 10 women - with a median age of 30 and a maximum of 44. All patients presented either a lump in the temporal region or prominent temporal arteries, and 47.7% of patients suffered from headaches. Only 11.4% of patients presented general symptoms and 6.8% a biological inflammatory syndrome; 34.1% had peripheral blood eosinophilia; 83.7% presented a single episode and complete excision without further treatment was documented for 72.7%. Pathology analysis revealed infiltrate of inflammatory cells in the arterial wall in 97.6% of patients but also sparse giant cells for 25% and granuloma for 22.9%, perivascular extension of the inflammation for 82.6%, and presence of lymphoid follicles or germinal centres for 60%. Clinical relapses were present in 16.3% of cases. CONCLUSION: JTA is a rare, localized and benign disease. The majority of cases have only one episode which is cured by local surgery.


Asunto(s)
Arteritis de Células Gigantes , Arterias Temporales/patología , Adolescente , Adulto , Biopsia , Femenino , Francia/epidemiología , Arteritis de Células Gigantes/diagnóstico , Arteritis de Células Gigantes/epidemiología , Arteritis de Células Gigantes/patología , Arteritis de Células Gigantes/terapia , Cefalea/diagnóstico , Cefalea/etiología , Cefalea/terapia , Humanos , Masculino , Estudios Retrospectivos , Síndrome , Adulto Joven
4.
Medicine (Baltimore) ; 96(47): e8423, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29381919

RESUMEN

In cystic fibrosis patients, electrolytic and osmolality imbalance secondary to cystic fibrosis transmembrane conductance regulator mutations may impact on mucoid secretion accumulation and secondary colonization by opportunistic pathogens such as nontuberculous mycobacteria.We performed a noninvasive exploratory prospective controlled clinical study comparing sputum salinity and acid-base characteristics of cystic fibrosis and noncystic fibrosis control patients. A total of 57 patients and 62 controls were included.Sputum salt concentrations were 10.5 g/L (95% CI: 7.7-13.3) in patients and 7.4 g/L (95% CI: 5.9-8.9) in aged-matched controls, a difference that was found to be statistically significant (P < .05). No difference in pH was observed between patients and controls.These differences in respiratory secretions salt concentrations could influence host-pathogen interactions in the context of cystic fibrosis respiratory infections. We propose to include respiratory secretion salt measurement as a routine analysis on cystic fibrosis patients' sputum submitted for bacterial culture.


Asunto(s)
Fibrosis Quística/patología , Cloruro de Sodio/análisis , Esputo/química , Adolescente , Adulto , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Sistema Respiratorio , Adulto Joven
5.
Am J Clin Dermatol ; 17(6): 635-642, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27591889

RESUMEN

Although exercise-induced vasculitis (EIV) is usually misdiagnosed, it is not uncommon. Occurring mostly after prolonged exercise, especially in hot weather, EIV is an isolated cutaneous vasculitis with stereotypical presentation. This article reviews the clinical characteristics, treatments, and outcomes of EIV based on the published literature. We report 99 patients who developed EIV after walking, dancing, swimming, or hiking especially during hot weather, including the records of 16 patients with EIV treated at our hospital from 2007 to 2015. Erythematous or purpuric plaques arise on the lower legs, without the involvement of compression socks or stockings. Symptoms include itch, pain, and a burning sensation. EIV is an isolated cutaneous vasculitis. Lesions resolve spontaneously after 10 days. When triggering conditions persist, relapses are frequent (77.5 %). Histopathology demonstrates leukocytoclastic vasculitis in 95 % of cases with C3 or immunoglobulin M deposits in 88 and 46 % of cases, respectively. Blood investigations are negative. EIV appears to be a consequence of venous stasis induced by an acute failure of the muscle pump of the calf and thermoregulation decompensation. Both appear after prolonged and unusual exercise in hot weather. Treatment is not codified; topical corticosteroids may reduce symptoms and wearing light clothes might limit lesion occurrence.


Asunto(s)
Ejercicio Físico , Glucocorticoides/uso terapéutico , Antagonistas de los Receptores Histamínicos/uso terapéutico , Vasculitis Leucocitoclástica Cutánea , Biopsia , Regulación de la Temperatura Corporal , Femenino , Calor/efectos adversos , Humanos , Pierna , Masculino , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Piel/patología , Medias de Compresión , Resultado del Tratamiento , Vasculitis Leucocitoclástica Cutánea/etiología , Vasculitis Leucocitoclástica Cutánea/patología , Vasculitis Leucocitoclástica Cutánea/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...